Cornelia Mauch
Kerpener Str. 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 132 publications
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.
Journal: Future oncology (London, England)
Published: March 31, 2026
The Interstitial Collagenases MMP13 and MMP14 Are Dispensable for the Early Onset of Skin Morphogenesis but Modulate Endochondral Ossification.
Journal: The American journal of pathology
Published: November 07, 2025
The interstitial collagenases MMP13 and MMP14 are dispensable for the early onset of skin morphogenesis, but modulate endochondral ossification.
Journal: The American journal of pathology
Published: November 07, 2025
Combining immune-related adverse events and inflammatory profiles enhances prognostic accuracy in metastatic melanoma under PD-1-based therapy.
Journal: Frontiers in immunology
Published: August 11, 2025
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 24, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 07, 2024
Excellent response to cemiplimab and radiotherapy in advanced metastatic porocarcinoma.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 25, 2024
New insights into the structural role of EMILINs within the human skin microenvironment.
Journal: Scientific reports
Published: April 23, 2024
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 20, 2024
Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case report.
Journal: Frontiers in immunology
Published: October 19, 2023
TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients.
Journal: BMC cancer
Published: July 29, 2023
Last Updated: 09/26/2026